Epocrates to Present at the 31st Annual J.P. Morgan Healthcare Conference

Epocrates to Present at the 31st Annual J.P. Morgan Healthcare Conference

SAN MATEO, Calif., Dec. 17, 2012 (GLOBE NEWSWIRE) -- Epocrates, Inc.
(Nasdaq:EPOC), a leading physician platform for clinical content, practice
tools and health industry engagement, announced today that it will participate
in the 31st Annual J.P. Morgan Healthcare ConferenceinSan Francisco,
Calif.Andrew Hurd, president, chief executive officer and interim chief
financial officer, will present at the conference at2:30 p.m. PSTonMonday,
January 7, 2013.

A live audio webcast of the presentation will be available in the Investor
Relations section of the Epocrates website at http://investor.epocrates.com.
The webcast will also be available for replay approximately one hour after
conclusion of the live event.

About Epocrates, Inc.

Epocrates, Inc. (Nasdaq:EPOC) is recognized for developing the #1 medical
application among U.S. physicians for clinical content, practice tools and
health industry engagement at the point of care.Epocrates has established a
loyal network ofmore than one million healthcare professionals, including 50
percent of U.S. physicians, who routinely use its intuitive solutions to help
streamline workflow and improve patient care.The company also facilitates the
delivery of valuable content and tools between partnering organizations and
its members. For more information, please visitwww.epocrates.com/company.

Epocrates is a trademark of Epocrates, Inc., registered in the U.S. and other

The Epocrates, Inc. logo is available at

Forward-Looking Statements

All statements contained in this press release, other than statements of
historical fact, are forward-looking statements intended to qualify for the
safe harbors from liability established by the Private Securities Litigation
Reform Act of 1995. Forward-looking statements by their nature address matters
that are, to different degrees, uncertain. The forward-looking statements
include uncertainties and risks including, among others: the inability to
retain and expand the Epocrates physician network at the rate expected;
unexpected delays in delivering new products; lack of market acceptance of new
products; the inability to maintain product quality and brand credibility; the
inability to keep up with the technological advances within the marketplace
and by competitors; the inability to realize estimates and guidance made by
management with respect to Epocrates' financial results; and other factors,
including general economic conditions and regulatory developments not within
Epocrates' control. The factors discussed herein and expressed from time to
time in Epocrates' filings with the Securities and Exchange Commission could
cause actual results and developments to be materially different from those
expressed in or implied by such statements.The forward-looking statements are
made only as of the date of this press release, and except as required by law,
Epocrates undertakes no obligation to publicly update its forward-looking
statements to reflect subsequent events or circumstances. You should review
the Epocrates filings, especially the risk factors contained in its most
recent filings with the Securities and Exchange Commission on Form 10-K and
Form 10-Q.

         Erica Sniad Morgenstern
         Senior Director, Public Relations and Communications
         Epocrates, Inc.
         (650) 227-6907

Epocrates, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.